Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
agreeement, bioavailable, burden, Calif, chairmanship, Chawla, climate, conjugate, consuming, contacted, converge, county, cytogenetic, Dance, decided, destruction, dispute, disruption, earthquake, Eastern, equitoxic, escrow, expropriation, familiar, famine, fire, flood, frequency, Galena, gemcitzbine, Gilead, great, grew, hearing, hematopoietic, Hungary, India, instability, insurrection, invaluable, jury, Mexican, mild, moderately, monetizing, Monica, nausea, necessity, neutrophil, notification, Orphazyme, panel, platelet, political, rare, region, riot, RNA, Romania, Russia, Sant, schema, signaling, social, ssued, stayed, stem, storm, terrorism, thse, transplantation, Ukraine, undertook, underwriting, underwritten, undisclosed, unfamiliar, unforeseen, unresectable, unrest, war, white, Xalkori
Removed:
Adjustable, allocated, amplification, approach, arrive, assumed, attendance, barrier, Biorex, BioScience, book, brain, BRX, calculating, cashed, Cephalon, chosen, conditioned, consisted, Contingently, conventional, convertible, converting, declare, deconsolidation, delivery, depressed, desirable, diabetic, discriminate, dispose, dramatic, economy, EITF, endothelial, entitle, equipping, eventually, exchangeable, exercising, expenditure, extend, FIN, Friedman, goodwill, Guarantor, healing, hierarchy, highest, Hunter, identifiable, impossible, indexed, ingredient, Kenneth, molecule, noncontrolling, outlay, parent, Parkinson, Pine, plasma, positive, prodrug, producing, profile, progression, quantity, Ramsey, randomly, recently, Red, refocused, retroactively, Robert, Roche, RT, SAB, satisfied, securing, sickle, stroke, Task, taxation, transferability, transferable, TranzFect, trisenox, unconsolidated, vi, wholly, wound
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Amended and Restated Certificate of Incorporation of Cytrx Corporation, As Amended
- 10.6 Cytrx Corporation Amended and Restated 2008 Stock Incentive Plan
- 10.12 Third Amendment to Third Amended and Restated Employment Agreement, Dated January 1, 2012, Between Cytrx Corporation and Steven A. Kriegsman
- 10.20 Employment Agreement Dated January 1, 2012 Between Cytrx Corporation and Daniel Levitt, M.D., PH.D.
- 10.21 Employment Agreement Dated January 1, 2012, Between Cytrx Corporation and Scott Geyer
- 10.22 Employment Agreement Dated January 1, 2012, Between Cytrx Corporation and Benjamin S. Levin
- 10.23 Employment Agreement Dated January 1, 2012, Between Cytrx Corporation and Scott Wieland
- 10.24 Employment Agreement Dated January 1, 2012, Between Cytrx Corporation and John Y. Caloz
- 10.26 Investment Banking Agreement Dated February 14, 2012, Between Cytrx Corporation and Legend Securities, Inc.
- 23.1 Consent of Bdo USA, LLP
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
Related press release
LADX similar filings
Filing view
External links
Exhibit 32.1
Certification of Chief Executive Officer
Pursuant to 18 U.S.C. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of CytRx Corporation (the “Company”) hereby certifies that:
(i) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 12, 2012 | By: | /s/ STEVEN A. KRIEGSMAN | |
Steven A. Kriegsman | |||
Chief Executive Officer | |||
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 (Section 906), or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to CytRx Corporation and will be retained by CytRx Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an Exhibit to the Form 10-K and shall not be considered filed as part of the Form 10-K.